Saccharomyces boulardii Preserves the Barrier Function and Modulates the Signal Transduction Pathway Induced in Enteropathogenic Escherichia coli-Infected T84 Cells

ABSTRACT Use of the nonpathogenic yeast Saccharomyces boulardiiin the treatment of infectious diarrhea has attracted growing interest. The present study designed to investigate the effect of this yeast on enteropathogenic Escherichia coli (EPEC)-associated disease demonstrates that S. boulardii abrogated the alterations induced by an EPEC strain on transepithelial resistance, [3H]inulin flux, and ZO-1 distribution in T84 cells. Moreover, EPEC-mediated apoptosis of epithelial cells was delayed in the presence of S. boulardii. The yeast did not modify the number of adherent bacteria but lowered by 50% the number of intracellular bacteria. Infection by EPEC induced tyrosine phosphorylation of several proteins in T84 cells, including p46 and p52 SHC isoforms, that was attenuated in the presence of S. boulardii. Similarly, EPEC-induced activation of the ERK1/2 mitogen-activated protein (MAP) kinase pathway was diminished in the presence of the yeast. Interestingly, inhibition of the ERK1/2 pathway with the specific inhibitor PD 98059 decreased EPEC internalization, suggesting that modulation of the ERK1/2 MAP pathway might account for the lowering of the number of intracellular bacteria observed in the presence of S. boulardii. Altogether, this study demonstrated that S. boulardii exerts a protective effect on epithelial cells after EPEC adhesion by modulating the signaling pathway induced by bacterial infection.

[1]  M. Borrello,et al.  The multiple endocrine neoplasia type 2B point mutation switches the specificity of the Ret tyrosine kinase towards cellular substrates that are susceptible to interact with Crk and Nck , 1997, Oncogene.

[2]  D. Philpott,et al.  Infection of T84 cells with enteropathogenic Escherichia coli alters barrier and transport functions. , 1996, The American journal of physiology.

[3]  B. Finlay,et al.  Enteropathogenic Escherichia coli decreases the transepithelial electrical resistance of polarized epithelial monolayers , 1993, Infection and immunity.

[4]  John K. Crane,et al.  Host Cell Death due to EnteropathogenicEscherichia coli Has Features of Apoptosis , 1999, Infection and Immunity.

[5]  B. Finlay,et al.  Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication. , 1988, Biochimie.

[6]  S. Falkow,et al.  A molecular strategy for the study of bacterial invasion. , 1987, Reviews of infectious diseases.

[7]  P. Sansonetti,et al.  Apoptosis in Bacterial Pathogenesis , 1996 .

[8]  J. R. Andrade,et al.  An endocytic process in HEp-2 cells induced by enteropathogenic Escherichia coli. , 1989, Journal of medical microbiology.

[9]  L. Mcfarland,et al.  Saccharomyces boulardii : A Review of an Innovative Biotherapeutic Agent , 2022 .

[10]  P. Williams,et al.  Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli , 1989, Infection and immunity.

[11]  G. Schoolnik,et al.  Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. , 1998, Science.

[12]  B. Finlay,et al.  Salmonella interactions with polarized human intestinal Caco-2 epithelial cells. , 1990, The Journal of infectious diseases.

[13]  B. Finlay,et al.  Signal transduction between enteropathogenic Escherichia coli (EPEC) and epithelial cells: EPEC induces tyrosine phosphorylation of host cell proteins to initiate cytoskeletal rearrangement and bacterial uptake. , 1992, The EMBO journal.

[14]  G. Keusch,et al.  Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. , 1989, The Journal of infectious diseases.

[15]  E. Bambirra,et al.  Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic mice. , 1996, The Journal of applied bacteriology.

[16]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[17]  S. Falkow,et al.  The role of host tyrosine phosphorylation in bacterial pathogenesis. , 1993, Trends in genetics : TIG.

[18]  B. Finlay,et al.  Cytoskeletal composition of attaching and effacing lesions associated with enteropathogenic Escherichia coli adherence to HeLa cells , 1992, Infection and immunity.

[19]  P. Sherman,et al.  Signal transduction in human epithelial cells infected with attaching and effacing Escherichia coli in vitro. , 1994, Gastroenterology.

[20]  Gedek.  Adherence of Escherichia coli serogroup 0 157 and the Salmonella Typhimurium mutant DT 104 to the surface of Saccharomyces boulardii , 1999, Mycoses.

[21]  P. Sansonetti,et al.  Perspectives series: host/pathogen interactions. Apoptosis in bacterial pathogenesis. , 1997, The Journal of clinical investigation.

[22]  B. Finlay,et al.  A diarrheal pathogen, enteropathogenic Escherichia coli (EPEC), triggers a flux of inositol phosphates in infected epithelial cells , 1994, The Journal of experimental medicine.

[23]  M. Ulshen,et al.  Pathogenesis of escherichia coli gastroenteritis in man--another mechanism. , 1980, The New England journal of medicine.

[24]  B. Finlay,et al.  Listeria monocytogenes Invasion of Epithelial Cells Requires the MEK-1/ERK-2 Mitogen-Activated Protein Kinase Pathway , 1998, Infection and Immunity.

[25]  B. Hirst,et al.  Increased tyrosine phosphorylation causes redistribution of adherens junction and tight junction proteins and perturbs paracellular barrier function in MDCK epithelia. , 1998, European journal of cell biology.

[26]  L. Trabulsi,et al.  Distinctive patterns of adherence of enteropathogenic Escherichia coli to HeLa cells , 1984, Infection and immunity.

[27]  B. Gedek,et al.  Mikrobieller Antagonismus: Zur Eliminierung von enteropathogenen E. coli-Keimen und Salmonellen aus dem Darm durch Saccharomyces boulardii , 1990 .

[28]  M. Levine,et al.  Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines , 1983, Infection and immunity.

[29]  R. Davis,et al.  The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.

[30]  U. Fagundes-neto,et al.  Enteropathogenic Escherichia coli Oillab:H2 penetrates the small bowel epithelium in an infant with acute diarrhoea , 1995, Acta paediatrica.

[31]  A. Mariano,et al.  Enteropathogenicity markers in Escherichia coli isolated from infants with acute diarrhoea and healthy controls in Rio de Janeiro, Brazil. , 1998, Journal of medical microbiology.

[32]  C. Surawicz,et al.  Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. , 1996, JAMA.

[33]  G. Zampighi,et al.  Uncoupling of the molecular 'fence' and paracellular 'gate' functions in epithelial tight junctions , 1993, Nature.

[34]  S. Tzipori,et al.  Enteropathogenic Escherichia coli enteritis: evaluation of the gnotobiotic piglet as a model of human infection. , 1985, Gut.

[35]  S. Savkovic,et al.  Enteropathogenic Escherichia coli-induced myosin light chain phosphorylation alters intestinal epithelial permeability. , 1997, Gastroenterology.

[36]  R. Davis,et al.  Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. , 1997, Journal of immunology.

[37]  P. Rampal,et al.  [Response to cholera toxin of 2 epithelial intestinal cell lines. Effect of Saccharomyces boulardii]. , 1989, Gastroenterologie clinique et biologique.

[38]  M. Craynest,et al.  Response of Human and Rat Small Intestinal Mucosa to Oral Administration of Saccharomyces boulardii , 1986, Pediatric Research.